These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12804854)

  • 21. Early protection in sheep against intratypic heterologous challenge with serotype O foot-and-mouth disease virus using high-potency, emergency vaccine.
    Horsington J; Zhang Z; Bittner H; Hole K; Singanallur NB; Alexandersen S; Vosloo W
    Vaccine; 2015 Jan; 33(3):422-9. PubMed ID: 25483241
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective effects of high-potency FMDV O
    Horsington J; Perez CB; Maradei E; Novo SG; Gonzales JL; Singanallur NB; Bonastre P; Vosloo W
    Vaccine; 2017 Sep; 35(38):5179-5185. PubMed ID: 28789849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneity in the Antibody Response to Foot-and-Mouth Disease Primo-vaccinated Calves.
    Di Giacomo S; Brito BP; Perez AM; Bucafusco D; Pega J; Rodríguez L; Borca MV; Pérez-Filgueira M
    Transbound Emerg Dis; 2015 Jun; 62(3):280-7. PubMed ID: 23895140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chimeric foot-and-mouth disease viruses: evaluation of their efficacy as potential marker vaccines in cattle.
    Fowler VL; Paton DJ; Rieder E; Barnett PV
    Vaccine; 2008 Apr; 26(16):1982-9. PubMed ID: 18342409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of immune responses of stabilised SAT2 antigens of foot-and-mouth disease in cattle.
    Scott KA; Rathogwa NM; Capozzo AV; Maree FF
    Vaccine; 2017 Sep; 35(40):5426-5433. PubMed ID: 28431813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Foot-and-mouth disease vaccine potency testing: the influence of serotype, type of adjuvant, valency, fractionation method, and virus culture on the dose-response curve in cattle.
    Jamal SM; Bouma A; van den Broek J; Stegeman A; Chénard G; Dekker A
    Vaccine; 2008 Nov; 26(50):6317-21. PubMed ID: 18822336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proper quality control of formulated foot-and-mouth disease vaccines in countries with prophylactic vaccination is necessary.
    Jamal SM; Shah SI; Ali Q; Mehmood A; Afzal M; Afzal M; Dekker A
    Transbound Emerg Dis; 2014 Dec; 61(6):483-9. PubMed ID: 23305464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigen and vaccine banks: technical requirements and the role of the european antigen bank in emergency foot and mouth disease vaccination.
    Lombard M; Füssel AE
    Rev Sci Tech; 2007 Apr; 26(1):117-34. PubMed ID: 17633297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of ENABL® adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine.
    Barrera J; Schutta C; Pisano M; Grubman MJ; Brake DA; Miller T; Kamicker BJ; Olutunmbi F; Ettyreddy D; Brough DE; Butman BT; Neilan JG
    Vaccine; 2018 Feb; 36(8):1078-1084. PubMed ID: 29358056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles.
    Pan L; Zhang Z; Lv J; Zhou P; Hu W; Fang Y; Chen H; Liu X; Shao J; Zhao F; Ding Y; Lin T; Chang H; Zhang J; Zhang Y; Wang Y
    Int J Nanomedicine; 2014; 9():5603-18. PubMed ID: 25506214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection in sheep against heterologous challenge with serotype Asia-1 foot-and-mouth disease virus using high potency vaccine.
    Horsington J; Nfon C; Gonzales JL; Singanallur N; Bittner H; Vosloo W
    Vaccine; 2018 Oct; 36(41):6095-6102. PubMed ID: 30195485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Avidity and subtyping of specific antibodies applied to the indirect assessment of heterologous protection against Foot-and-Mouth Disease Virus in cattle.
    Lavoria MÁ; Di-Giacomo S; Bucafusco D; Franco-Mahecha OL; Pérez-Filgueira DM; Capozzo AV
    Vaccine; 2012 Nov; 30(48):6845-50. PubMed ID: 23000129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Marker vaccine potential of a foot-and-mouth disease virus with a partial VP1 G-H loop deletion.
    Fowler VL; Knowles NJ; Paton DJ; Barnett PV
    Vaccine; 2010 Apr; 28(19):3428-34. PubMed ID: 20199761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FMD vaccine matching: Inter laboratory study for improved understanding of r
    Willems T; De Vleeschauwer A; Perez-Filgueira M; Li Y; Ludi A; Lefebvre D; Wilsden G; Statham B; Haas B; Mattion N; Robiolo B; Beascoechea Perez C; Maradei E; Smitsaart E; La Torre J; De Clercq K
    J Virol Methods; 2020 Feb; 276():113786. PubMed ID: 31765721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Foot and mouth disease vaccine potency tests in cattle: the interrelationship of antigen dose, serum neutralizing antibody response and protection from challenge.
    Pay TW; Hingley PJ
    Vaccine; 1992; 10(10):699-706. PubMed ID: 1326146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A potency test method for foot and mouth disease vaccine based on the serum neutralizing antibody response produced in cattle.
    Pay TW; Hingley PJ
    Vaccine; 1992; 10(10):707-13. PubMed ID: 1326147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple efficacy studies of an adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle using homologous challenge.
    Schutta C; Barrera J; Pisano M; Zsak L; Grubman MJ; Mayr GA; Moraes MP; Kamicker BJ; Brake DA; Ettyreddy D; Brough DE; Butman BT; Neilan JG
    Vaccine; 2016 Jun; 34(27):3214-3220. PubMed ID: 26707216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice.
    Ren ZJ; Tian CJ; Zhu QS; Zhao MY; Xin AG; Nie WX; Ling SR; Zhu MW; Wu JY; Lan HY; Cao YC; Bi YZ
    Vaccine; 2008 Mar; 26(11):1471-81. PubMed ID: 18289743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Herd Immunity Against Foot-and-Mouth Disease Under Different Vaccination Practices in India.
    Sharma GK; Mahajan S; Matura R; Biswal JK; Ranjan R; Subramaniam S; Misri J; Bambal RG; Pattnaik B
    Transbound Emerg Dis; 2017 Aug; 64(4):1133-1147. PubMed ID: 26920973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selection of foot and mouth disease vaccine strains--a review.
    Paton DJ; Valarcher JF; Bergmann I; Matlho OG; Zakharov VM; Palma EL; Thomson GR
    Rev Sci Tech; 2005 Dec; 24(3):981-93. PubMed ID: 16642769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.